Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.

Burn, John; Dennis, Martin; Bamford, John; Sandercock, Peter; Wade, Derick T; Warlow, Charles

doi:10.1161/01.str.25.2.333

Cited by 494 publications

(430 citation statements)

References 30 publications

(18 reference statements)

Supporting

Mentioning

379

Contrasting

Unclassified

Order By: Relevance

“…They deal with crisis reasons and causes, bankruptcy, crisis management, company state estimation, bankruptcy prediction and its methods. Characteristics of crisis situation were analyzed by Augustine (1995); Ayres (1996); Booth (2000); Burn, Redwood (2003); Demirguc-Kunt, Detragiache (1998); Hart (1993) ;Hwang, Lichtenthal (2000); Milburn et al (1993); Ravid, Sundgren (1998); Rogov (2006) ;Jasilionienė, Tamosiunienė (2009); problems of crisis management were discussed in the works of Ashcroft (1997); Alas (2008) ;Boin, Lagadec (2000); Darling et al (1996); ; Davidavičienė (2008); Donoho (1994); Escarraz, Chong (1998); Fink (2002); Kurosheva (Курoшева 2002); Lalonde (2004); Maynard (1993);Milesi-Ferritti, Razin (1998); Mitroff (2005); Murphy (2006); Ponikvar (2009);Paraskev (2006); Parsons (1996); Pearson, Clair (1998); Ulmer et al (2007); Valackiene Virbickaite (2009); causes of crisis and bankruptcy in a modern company were dealt with by Argenti (2005); Birch (1994); Grigaravičius (2002); Kaminsky (1998); ; Martin (1991); Preble (1997); Ren (2000); Rosenblatt, Sheaffer (2002); Rosenthal, Charl...…”

Section: Scientifi C Analysis Object Is the C Oncept Of Crisis Situatmentioning

confidence: 99%

Conceptualization of Crisis Situation in a Company / Įmonės Krizinės Situacijos Konceptualizacija

Valackienė

Virbickaitė

2011

Journal of Business Economics and Management

View full text Add to dashboard Cite

Abstract. The paper highlights theoretical construct of crisis situation in a company emphasizing the methodological positions of a social phenomenon. Applying systemic analysis of crisis situation in a company the paper discusses hardly spread social phenomenon, i.e. occurrence and expression of crisis situation in a company. On the basis of retrospective analysis of crisis situation, both crisis environment and bankruptcy features are presented and principal keywords defi ned with reference to crisis in a company as a social phenomenon and related to its environment: human, company-based, national and global. It shows the complexity of the scientifi c research object, that brings meaningful input into the analysis of crisis features in company life cycle. The paper aims at discussing and presenting critical reviews of crisis situation interpretations with emphasis on methodological positions of social phenomenon in different disciplines. The differences and links between crisis and crisis situation are also explained. Through explanation of logical construct of the paper, the authors specify crisis concept in a company: distinguishing negative changes in a company, that make the company staff apply crisis communication process and instrumentalities. In the above mentioned context the problem of crisis situation in a company remains signifi cant from psychological, social and economic and managerial perspectives.

show abstract

Section: Scientifi C Analysis Object Is the C Oncept Of Crisis Situatmentioning

confidence: 99%

Conceptualization of Crisis Situation in a Company / Įmonės Krizinės Situacijos Konceptualizacija

Valackienė

Virbickaitė

2011

Journal of Business Economics and Management

View full text Add to dashboard Cite

show abstract

“…7,8 Many patients who could benefit from antiplatelet, 9 anticoagulant, 10 or antihypertensive 11,12 medication do not receive it. Although stroke patients are at a high risk of further vascular events 13 and may benefit from secondary prevention, population-based data on their vascular risk management is limited, and most of the available studies comprise hospital-based cohorts. 14 -16 In England and Wales the prevention of vascular disease has been identified as a priority.…”

mentioning

confidence: 99%

Antithrombotic and Antihypertensive Management 3 Months After Ischemic Stroke

Hillen

Dundas

Lawrence

et al. 2000

Stroke

View full text Add to dashboard Cite

Background and Purpose-We sought to examine the frequency, predictors, and effects of nontreatment with antithrombotic and antihypertensive therapies 3 months after ischemic stroke. Methods-The population-based South London Community Stroke Register prospectively collected data on first-in-alifetime strokes between 1995 and 1997. Among patients registered with ischemic stroke, treatment status with antithrombotic and antihypertensive therapies was examined 3 months after the event. Results-In a cohort of 457 patients with ischemic stroke, 393 (86.0%) were considered appropriate for antiplatelet medication, 32 (7.0%) for anticoagulant medication, and 254 (55.9%) for antihypertensive medication. The rates of nontreatment observed 3 months after the event were 24.4% for antiplatelet, 59.4% for anticoagulant, and 29.5% for antihypertensive medication. Independent risk factors for nontreatment with antithrombotic therapies (antiplatelets and anticoagulants) were the subtype of stroke (nonlacunar infarct: ORϭ1.60, 95% CI 1.07 to 2.54), stroke severity measured by the Glasgow Coma Scale (GCS) score (GCS Յ13: OR 2.08, 95% CI 1.18 to 3.66) and the Barthel Index (BI) score 5 days after the event (BI Յ10: OR 1.85, 95% CI 1.17 to 2.93). For antihypertensive therapies the stroke subtype (OR 2.46, 95% CI 1.33 to 4.54), GCS score (OR 2.97, 95% CI 1.35 to 6.53), BI score (OR 2.33, 95% CI 1.27 to 4.29), and ethnicity (Caucasian: OR 2.43, 95% CI 1.15 to 5.14) were independently associated with nontreatment. Cox regression modeling showed no significant association between the treatment status and recurrence-free 3-year survival rates after controlling for severity and subtype of stroke. Conclusions-Secondary prevention for a common disease such as stroke appears to be inadequate in the study area.Healthcare professionals need to consider antithrombotic and antihypertensive therapies for all stroke patients. (Stroke. 2000;31:469-475.)

show abstract

“…15 Long-term risk of recurrent stroke after a firstever nonfatal stroke in the general population has been estimated at 30% actuarial risk by 5 years (9-fold increased risk vs nonstroke general population), with highest risk within the first year. 16 The decreased trend for stroke mortality after kidney transplant in our study cohort of stroke patients may reflect aggressive work up pretransplant to determine medical suitability and attenuation of cardiometabolic risk factors. However, this cannot be the complete explanation, as cardiovascular-related 55 Variables included in the model were age, gender, donor type (living vs deceased), socioeconomic deprivation, ethnicity, year of transplant, and selected medical comorbidities (ie, history of myocardial infarction, peripheral vascular disease, stroke, congestive cardiac failure pulmonary disease, liver disease, peptic ulcer, previous cancer and diabetes).…”

mentioning

confidence: 78%

Untitled

2016

Exp Clin Transplant

View full text Add to dashboard Cite

Objectives: Stroke is a major cause of mortality in the general population but data regarding stroke-related hospitalization or mortality after a kidney transplant is limited. We determined risk for stroke-related episodes after a kidney transplant in a populationbased cohort study of 19 103 kidney allograft recipients in England between 2001 and 2012. Materials and Methods:The incidence of stroke-related events after a kidney transplant with pretransplant history of stroke, the incidence of stroke-related hospitalization or death among all kidney allograft recipients after a kidney transplant, and risk factors for stroke-related mortality after a kidney transplant were examined. Data were obtained from hospital episode statistics (an administrative data warehouse that contains admissions to all National Health Service hospitals in England) and is linked to the Office for National Statistics, which collects information on all registered deaths in England. Results: There were 782 nonfatal stroke-related hospitalizations and 113 stroke-related deaths (5.4% of total deaths) after a kidney transplant (median follow-up 4.4 y after a kidney transplant). Risk for allcause mortality was higher for those recipients with, compared to those without, a history of stroke (21.5% vs 10.8%; P < .001). However, risk for stroke-related mortality after a kidney transplant was no different. Kidney allograft recipients with nonfatal stroke episodes after a transplant were at a higher risk for allcause and stroke-related mortality. In a Cox regression model, pretransplant history of stroke was an independent risk factor for all-cause mortality, but not stroke-related mortality, while posttransplant hospitalization with nonfatal stroke was a risk factor for both. Conclusions: Fatal and nonfatal stroke-related events are common among kidney allograft recipients. Further research is warranted to allow better risk stratification and facilitate clinical trials for risk attenuation of stroke after a kidney transplant. Key words: Cerebrovascular accident, Death, Transplant IntroductionStroke, or cerebrovascular accidents, is one of the leading causes of mortality in the world, estimated to be the second leading cause of global death by the World Health Organization. 1 In 2010, the global absolute numbers of individuals developing their first stroke, surviving stroke, or having a stroke-related death were 16.9 million, 33.0 million, and 5.9 million, with 69% of events occurring in individuals aged greater than 65 years. 2 In addition, stroke-related disability represents a significant health burden, with disability-adjusted life years lost an estimated 102 million globally in 2010. 2 Although age-standardized rates of stroke-related mortality are decreasing worldwide, 2,3 absolute numbers are increasing and they represent a major public health burden.In the context of transplant, the effect of strokerelated morbidity or mortality after a transplant is unclear because of a lack of published data. Oliveras and colleagues observed a 10-...

show abstract

Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.

Cited by 494 publications

References 30 publications

Conceptualization of Crisis Situation in a Company / Įmonės Krizinės Situacijos Konceptualizacija

Conceptualization of Crisis Situation in a Company / Įmonės Krizinės Situacijos Konceptualizacija

Antithrombotic and Antihypertensive Management 3 Months After Ischemic Stroke

Untitled

Contact Info

Product

Resources

About